Coronavirus replication requires proteolytic processing of the large polyprotein encoded by ORF1a/ab into putative functional intermediates and eventually ϳ15 mature proteins. The C-terminal ORF1a protein nsp10 colocalizes with viral replication complexes, but its role in transcription/replication is not well defined. To investigate the role of nsp10 in coronavirus transcription/replication, alanine replacements were engineered into a murine hepatitis virus (MHV) infectious clone in place of conserved residues in predicted functional domains or charged amino acid pairs/triplets, and rescued viruses were analyzed for mutant phenotypes. Of the 16 engineered clones, 5 viable viruses were rescued, 3 mutant viruses generated no cytopathic effect but were competent to synthesize viral subgenomic RNAs, and 8 were not viable. All viable mutants showed reductions in growth kinetics and overall viral RNA synthesis, implicating nsp10 as being a cofactor in positive-or negative-strand synthesis. Viable mutant nsp10-E2 was compromised in its ability to process the nascent polyprotein, as processing intermediates were detected in cells infected with this virus that were not detectable in wild-type infections. Mapping the mutations onto the crystal structure of severe acute respiratory syndrome virus nsp10 identified a central core resistant to mutation. Mutations targeting residues in or near either zinc-binding finger generated nonviable phenotypes, demonstrating that both domains are essential to nsp10 function and MHV replication. All mutations resulting in viable phenotypes mapped to loops outside the central core and were characterized by a global decrease in RNA synthesis. These results demonstrate that nsp10 is a critical regulator of coronavirus RNA synthesis and may play an important role in polyprotein processing.
Coronaviruses (CoVs) have historically been associated with severe disease in important domestic animals and mild upper respiratory tract infections in humans (human CoV strains HCoV-229E and HCoV-OC43), rarely leading to severe disease (24) . However, the rapid identification of a CoV as the etiological agent responsible for severe acute respiratory syndrome (SARS) redefined historic perceptions. SARS-CoV spread globally and infected over 8,000 people, with mortality rates of about 10% (49) . More recent studies have identified human CoVs NL63 and HKU-1 as being important lower respiratory tract pathogens (25, 53) . With ubiquitous populations of CoVs found in many animals, it is not surprising that several newly identified CoVs that likely emerged from zoonotic reservoirs over the past 20 years have been described. An understanding of the basic biology and pathogenesis of CoV infection is of urgent importance.
CoVs are the largest known RNA viruses encoding plussense, 5Ј-capped, and polyadenylated genomes of 27 to 31 kb in length. CoVs are classified as members of the order Nidovirales, family Coronaviridae, genus Coronavirus, and are divided into three groups based on serological and phylogenetic categorizations (14, 29) . Group 1 consists of NL63, HCoV-229E, and transmissible gastroenteritis virus; group 3 is composed of infectious bronchitis virus; and group 2 CoVs include HCoV-OC43, HKU-1, bovine CoV, SARS-CoV, and murine hepatitis virus (MHV) (14) . MHV is an extensively studied CoV, with strain MHV-A59 being well characterized in cell culture and mouse model systems (33) . The close relationship of MHV to SARS-CoV makes MHV an ideal model for prototype studies of the biology and pathogenesis of CoV infections in humans.
The first ϳ22 kb of the CoV genome is organized as two overlapping open reading frames (ORFs), which encode the replicase genes (ORF1a and ORF1ab), while the remaining 5 to 9 kb contains the genes that encode (i) structural proteins common to all CoVs, including spike (S), envelope (E), matrix (M), and nucleocapsid (N) proteins, and (ii) accessory ORFs that encode proteins unique to specific virus groups (24) . The structural and accessory proteins are encoded by a nested set of coterminal subgenomic mRNAs that are generated by discontinuous transcription of negative strands (1, 21, 39, 40, 42-44, 46, 57) , followed by positive-strand synthesis and then translation.
Immediately after entry, the genomic RNA is uncoated, and the translation of ORF1 generates either a ϳ500-kDa polyprotein (pp1a) from ORF1a or an ϳ800-kDa polyprotein (pp1ab), which is translated only when the ORF1a stop codon is overridden by a Ϫ1 ribosomal frameshift that allows the translation of an ORF1ab fusion protein (5) . ORF1ab translation occurs at an approximate frequency of 25 to 30%, which leads to a greater-than-threefold enrichment of proteins translated from pp1a (4) . During and after translation, pp1a and pp1ab are processed by three functionally active virally encoded proteinases into active intermediates and eventually ϳ15 mature proteins (6) .
Two distinct types of viral proteinases are required to process the nascent polyprotein into component intermediates and mature proteins. The first type is the Papain-like proteinases (PLP1 and PLP2), which cleave nonstructural proteins (nsp1 to nsp3) cotranslationally (7, 8, 18, 45) , resulting in mature proteins nsp1, nsp2, and nsp3 as well as polyproteins nsp4 to 11 and nsp4 to 16. These polyprotein intermediates are then processed both cotranslationally and posttranslationally by the second type, a 3C-like proteinase known as 3CLpro or main proteinase (Mpro) (11) . Although the exact order and mechanism of processing of mature proteins from these intermediates are yet to be determined, most of these proteins have been observed in their mature form and colocalize with the viral RNA-dependent RNA polymerase to intracellular double-membrane vesicles, where they form the viral replication complex (16) . The current model suggests that larger unprocessed intermediates such as nsp4-10/11 (p150) play a role in early negative-strand synthesis, while positive-strand replication is thought to require mature proteins (41) . To date, only nsp2 has been shown to be dispensable for replication (17) .
In general, nsp1 and nsp2 have unknown functions, nsp3 contains domains important for transcriptional regulation as well as for PLP1 and PLP2 activity, nsp4 and nsp6 are transmembrane domains that may aid in anchoring the replication complex to double-membrane vesicles, and nsp5 is the 3CLpro. nsp7 to nsp10 are four small proteins of unknown function found at the carboxy-terminal end of pp1a. The structures of nsp7 (34) nsp7-nsp8 (56), nsp9 (13, 52) , and nsp10 (22, 51) have been solved, and all four proteins have been implicated in RNA synthesis. nsp7 and nsp8 are predicted to form a hollow cylinder postulated to protect double-stranded RNA during transcription/replication (56) , nsp8 has a demonstrated RNA primase activity (20) , nsp9 has been shown to bind singlestranded RNA (13, 52) , and three studies with nsp10 predict that it interacts with RNA, DNA, and/or other proteins (22, 28, 51) . nsp11 is a small ϳ36-nucleotide (nt) segment located at the 3Ј end of ORF1a that encodes a small uncharacterized 12-amino-acid peptide with no defined function. nsp12 is the RNA-dependent RNA polymerase (RdRp), nsp13 contains the helicase activity, and nsp14 to nsp16 are enzymes that may function in RNA processing (48) .
Studies with nsp10 have shown that it is a 15-kDa protein of unknown function that has been shown to interact with itself, nsp1, and nsp7 (8) . It colocalizes with N to sites of viral replication (3) and is essential for replication (D. Deming et al., unpublished data). nsp10 was first predicted to be a possible growth factor-like molecule, as the concentration of nsp10 increased in response to epidermal growth factor (30); however, there is little homology between nsp10 and any other proteins of known function. Complementation studies using temperature-sensitive mutants in several nsp's of MHV have purported that nsp10, along with nsp4, nsp5, nsp12, nsp14, and nsp16, is essential for the assembly of a functional replication/ transcription complex (41) . Further characterization of the nsp10 temperature-sensitive mutant TS-LA6 has suggested that nsp10 plays a critical role in negative-strand elongation (41, 47, 54) . Recent crystallography studies have revealed the structure of nsp10 of SARS-CoV to be a novel zinc finger protein with two zinc finger domains (22, 51) , whereas a second report suggested that the biological unit is a dodecamer that forms a hollow, positively charged cylinder that is thought to be a transcription factor (22, 51) .
In this study, we employed a reverse-genetics approach to generate mutants of nsp10 in the context of the entire virus to define the functions of nsp10 in CoV replication/transcription. We show that rescued viruses with mutations in nsp10 globally reduce viral RNA synthesis. Mutations resulting in lethal phenotypes mapped to a central core of nsp10 that is resistant to mutation and verified that the zinc-binding fingers (ZFs), including the surrounding residues to which they hydrogen bond, are critical to nsp10 function and CoV viability. Finally, our study is the first study to demonstrate that mutations in nsp10 may affect the processing of the ORF1a/ORF1ab polyprotein.
MATERIALS AND METHODS

Virus and cells.
For this study, we used an infectious clone of MHV-A59 developed by our laboratory, which is comprised of seven fragments maintained in pSMART (Lucigen) or pCR-XL-TopoA (Invitrogen) vectors and was amplified according to previously published protocols (55) . Recombinant MHV generated by the infectious clone (wt-icMHV) was used as a control in each experiment. The MHV sequence under GenBank accession number NC_001846 was used for primer and cloning design. Delayed brain tumor (DBT) cells were maintained at 37°C in minimum essential medium supplemented with 10% fetal clone II (Gibco), 10% tryptose phosphate broth, and gentamicin (0.05 g/ml)-kanamycin (0.25 g/ml). Baby hamster kidney (BHK) cells exogenously expressing MHV receptor (MHVr) (BHK-MHVr) were maintained at 37°C in the same medium described above with the addition of geneticin (0.8 mg/ml) to select for cells expressing MHVr.
Bioinformatics analysis and mutant rationale. A multiple sequence alignment generated by the National Center for Biotechnology Information (NCBI) (http: //www.ncbi.nlm.nih.gov/genomes/SARS/nsP7.html) was used to map the conserved features of nsp10. Bioinformatic predictions were generated using Prosite (19) to predict conserved protein domains, Predictors of Natural Disordered Regions (38) to determine putative disordered domains, the SMART database (26) to search for similarity signatures, and HMMSearch (12) to analyze potential structurally conserved subunits.
Generating mutants. A full-length molecular clone developed by our laboratory (55) was used to engineer the appropriate mutations in the nsp10 sequence, which is found in the MHV-E fragment (55) . Briefly, primers that incorporated type IIS restriction enzyme sites (BbsI) bearing each mutation onto the ends of two amplicons that comprised MHV-E (55) were designed (Table 1) . In all cases, the wild-type residue(s) was changed to alanine by altering two positions in each codon. The mutants were generated by PCR, cloned into the Topo-XL vector (Invitrogen), grown up in competent Top10 cells (Invitrogen), screened by restriction digestion, and sequenced to verify that the correct changes were added onto each end. Each amplicon was then digested with BbsI and ligated to form the mutated MHV-E fragment. Full-length E constructs were amplified and purified, and the sequence was verified. For assembling the infectious clone, plasmids incorporating cDNA fragments of MHV-A through MHV-G for wticMHV and MHV-A to MHV-D, MHV-F, MHV-G, and the mutated E construct for each mutant were transformed into chemically competent Top10 cells (Invitrogen) by heat shock at 42°C for 2 min and then plated onto Luria Bertani (LB) plates with appropriate selection (kanamycin [25 g/ml] for Topo-XL and ampicillin [50 g/ml] for pSMART). Colonies were picked and grown under appropriate selection conditions in 5 ml of LB broth maintained at 28.5°C for 16 to 24 h and then purified and screened by restriction digestion. Larger 20-ml stocks were grown at 28.5°C for 24 h for each of the cDNAs. Purified plasmids were then digested with MluI and BsmBI for MHV-A; BglI and BsmBI for MHV-B and MHV-C; BsmBI for MHV-D, MHV-E, and MHV-F; and SfiI and BsmBI for MHV-G (55). After digestion, fragments were electroporated on an 0.8% agarose gel, and appropriate bands were excised and gel purified using a Qiaex II gel extraction kit (QIAGEN) with modifications (55) . Briefly, all fragments were resuspended in 620 l of QX1 buffer, 11 l QIAEX II silica gel particles, and 12.5 l 3 M sodium acetate and eluted in 35 l of elution buffer heated to 70°C. Purified fragments were ligated overnight at 4°C in a total VOL. 81, 2007 MHV nsp10 REGULATES VIRAL RNA SYNTHESIS 6357 reaction mixture volume of ϳ200 l. The full-length cDNA was then further purified by chloroform extraction and isopropanol precipitation, transcribed using T7 transcription kit (Ambion), and cotransfected into 8 ϫ 10 6 BHK-MHVr cells in parallel with the N gene driven by an SP6 promoter and transcribed with an SP6 transcription kit (Ambion). Electroporated BHK cells were poured onto ϳ2.5 ϫ 10 5 DBT cells seeded in T75 flasks and incubated at 37°C for 24 to 72 h. Flasks were examined at regular intervals for cytopathic effects (CPEs), and viable mutants were verified by reverse transcriptase PCR (RT-PCR) of subgenomic RNA using primers targeting the leader sequence and the 5Ј end of the N gene (Table 1) . Plaque-purified viruses were sequenced to confirm that the correct mutations were present in the recombinant virus.
Growth kinetics and RNA analysis. Viral stocks were propagated in DBT cells for each viable mutant, and titers were determined by plaque titration. For growth curve analysis, DBT cells were infected at a multiplicity of infection (MOI) of 0.2 PFU/cell in 60-mm plates with a 1-h adsorption period, followed by three washes with phosphate-buffered saline (PBS). Three milliliters of medium was added to each culture, and the infection was maintained at 37°C. Supernatants were harvested at 2, 4, 8, 12, and 16 h postinfection (p.i.), and titers were determined by plaque titration in DBT cells. For analysis of RNA, cells were infected at an MOI of 1 PFU/cell, and total RNA was harvested at 8 and 12 h in TRIzol reagent (Invitrogen). For Northern blot analysis, 1 g of total RNA from each mutant and wt-icMHV was separated by gel electrophoresis on a 1% agarose gel, transferred onto a nitrocellulose membrane, and probed with a 300-nt biotinylated RNA probe designed to detect the first ϳ300 nt of mRNA-7 (N gene) using an Ambion (Austin, TX) Northern kit. Bands were detected using the Bright Star Detection (Ambion) system, and membranes were exposed to film.
Reverse transcription, RT-PCR, and real-time PCR. Viral RNA was reverse transcribed to cDNA using SuperScript III (Invitrogen) with modifications to the protocol as follows. Random hexamers (300 ng) and total RNA (5 g) were incubated for 10 min at 70°C. The remaining reagents were then added according to the manufacturer's recommendations, and the reaction mixture was incubated at 55°C for 1 h, followed by 20 min at 70°C to deactivate the RT. For RT-PCR, a forward primer in the leader sequence and a reverse primer ϳ200 nt into the N gene (Table 1) were used to generate a ϳ220-bp product by PCR.
Quantitative real-time RT-PCR was conducted using Smart Cycler II (Cepheid) with SYBR green (diluted to 0.25ϫ; Cepheid) to detect subgenomic cDNA with primers (7.5 pmol) optimized to detect ϳ120 nt spanning from the leader sequence to the 5Ј end of the N gene (Table 1) or genomic cDNA with primers (7.5 pmol) optimized to detect ϳ120 nt of ORF1a ( Table 1 ). The cDNA from the RT reaction mixture of each virus was diluted 1:10 3 , and 1 l was used for each reaction mixture, with a total reaction mixture volume of 25 l. Omnimix beads (Cepheid) containing all reagents except SYBR green, primer, and template were used to standardize the reaction conditions, and template concentrations were normalized by concentrations of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). In addition, all products were verified by melting curve analysis.
Statistical methods. Three independent infections for each mutant were analyzed by real-time PCR, and differences in copy numbers for genomic and subgenomic RNAs were tested using the paired t test with an ␣ value of 0.05.
Immunoprecipitation analysis. DBT cells were infected at an MOI of 2 PFU/ml for 2 h, at which time the medium was removed and replaced with medium lacking Met-Cys but containing 20 g/ml of actinomycin D (Sigma) and incubated at 37°C for an additional 2 h. At 4 h p.i., [ 35 S]methionine-cysteine (0.08 mCi/ml) was added to the infections, and cells were harvested at 9 h. Radiolabeled cells were washed in 1 ml of PBS and then resuspended in 1 ml of cold ST buffer (200 mM sucrose, 10 mM Tris [pH 7.4]). Next, cells were homogenized by 40 passes through a ball-bearing homogenizer and transferred into fresh tubes. Homogenates were then spun at 6,000 ϫ g for 3 min at room temperature, and the supernatant was transferred into ultracentrifuge tubes and spun at 300,000 ϫ g for 15 min at 4°C. The supernatant was then transferred into a fresh tube (S100), and the pellet was resuspended in 1 ml of ST buffer (P100). The nuclear pellet was resuspended in 1 ml of ST buffer, and the DNA was sheared by passage 20 times through a 20-gauge needle. Lysates were boiled for 5 min in sodium dodecyl sulfate (SDS) at a final concentration of 1% and then combined with protein A-Sepharose beads and a 1:200 dilution of anti-nsp10 antibody (VU128) in no-SDS lysis buffer (1% NP-40, 150 mM sodium chloride, 0.5% sodium deoxycholate, and 50 mM Tris [pH 8.0]) supplemented with 1% SDS. After incubation at 4°C for 4 h, beads were pelleted and washed with low-salt lysis buffer (no-SDS lysis buffer plus 150 mM NaCl), followed by high-salt lysis buffer (no-SDS lysis buffer with 1 M NaCl) and a final low-salt wash. After rinsing, 30 ml of 2ϫ SDS loading buffer (8% SDS, 0.2 M Tris [pH 8.8], 4 mM EDTA, 0.1% bromophenol blue, 40% glycerol, 0.5 M dithiothreitol) was added to the pelleted beads and boiled for 5 min prior to electrophoresis of the supernatant on 4 to 12% SDS-polyacrylamide gel electrophoresis (PAGE) gels.
IFA. DBT cells were grown to 60 to 70% confluence on 12-mm glass coverslips and infected with wt-icMHV or each of the viable mutants at an MOI of 5 PFU/cell. At 6.5 h p.i., the medium was aspirated, and the cells were fixed and permeabilized in methanol overnight at Ϫ20°C. Cells were rehydrated in PBS for 30 min and blocked in buffer comprised of PBS with 5% bovine serum albumin. All subsequent immunofluorescence assay (IFA) steps were conducted at 25°C in IFA wash buffer comprised of PBS containing 1% bovine serum albumin and 0.05% Nonidet P-40. After blocking, cells were incubated in primary antibody (anti-nsp10 [VU128] diluted 1:200 and anti-N diluted 1:1,000 or anti-M diluted 1:1,000) for 1 h. Cells were then washed in IFA wash buffer three times at 10 min/wash. Next, cells were incubated in secondary antibody (goat anti-rabbit Alexa 488 at a dilution of 1:1,000 and goat anti-mouse Alexa 546 at a dilution of 1:1,000; Molecular Probes) for 45 min. Next, cells were washed three times at 10 min/wash, followed by a final wash of 30 min in PBS. Coverslips were mounted onto slides with Aquapolymount (Polysciences), dried for 1 h, and then visualized by confocal immunofluorescence microscopy using a Zeiss LSM 510 laser scanning confocal microscope at 488 and 543 nm with a final magnification of ϫ40 with the oil immersion lens. Images were prepared for publication using Adobe Photoshop CS.
Analysis of structure. The crystal structure coordinates of SARS nsp10 (PDB accession number 2FYG) (22) were used as a template to generate a homology model of MHV nsp10, which is a predicted three-dimensional structure of this protein calculated from its sequence homology with SARS-CoV nsp10. Homology models were generated using the program Modeler, version 8.2 (15, 27) , with the automodel class. A pairwise alignment was generated using the SARS nsp10 protein database (PDB) file and the MHV homologue sequence (GenBank accession number NP_740615), and five models were generated from each alignment, with the best model selected based on the lowest objective-function score. Corresponding PDB files generated by this program were visualized using the molecular modeling tools MacPyMol (DeLano Scientific) and Chimera (35) . In addition, homology models of each of 16 mutants were generated using the same parameters.
RESULTS
Mutation design and rationale. To identify functional domains within MHV nsp10 and determine the roles that nsp10 plays in CoV replication, two different alanine-scanning mutagenesis strategies were devised. The first strategy targeted pairs and triplets of charged amino acids, since charged residues often provide electrostatic surface potential required for the interaction of the protein with other proteins or nucleic acids. These sites may play a crucial role in inter-and intraprotein interactions as well as nucleic acid binding, and these were designated the E-series mutants (Table 2 and Fig. 1) .
Bioinformatic methods identified an highly active region from amino acids 50 to 75 that contains multiple predicted protein domains and a disordered region potentially indicative of an interaction domain ( Fig. 1 and Table 2 ). The disordered region was not conserved at the amino acid level; however, the same amino acid positions were predicted by Predictors of Natural Disordered Regions (38) to be disordered in all CoVs, indicating that the conserved disordered region may play an important role in nsp10 function. Therefore, the second strategy targeted key residues in this region of nsp10 in an attempt to alter potential protein-protein or protein-nucleic acid interaction sites (Table 2 and Fig. 1 ) (38) or ablate putative functional domains (myristoylation sites, phosphorylation sites, etc.) ( Table 2 and Fig. 1 ). These mutants were designated the U-series mutants. All U-series mutant amino acids were conserved in nsp10 in all three groups of the Coronavirus genus ( Fig. 1 and Table 2 ), except mutant nsp10-U4, which targeted a nonconserved proline present in MHV and SARS-CoV. This change was predicted to add order to the conserved disordered region.
To determine the effects of nsp10 alanine-scanning mutagenesis on MHV replication, the 16 mutations were engineered into the molecular clone of MHV, replacing the wildtype amino acid(s) with alanine. In all cases, two nucleotide changes were made to each codon to reduce the likelihood of reversion to the wild-type sequence. The wild-type fragments of the molecular clone were isolated by restriction endonuclease digestion and ligated with the appropriate sequence-verified mutant fragment, and full-length cDNAs were then transcribed in vitro, transfected into replication-competent cell lines, and monitored for CPE, i.e., syncytium formation (55) .
Isolation and genotype of mutant viruses. MHV mutant viruses containing the mutations nsp10-U1, nsp10-U3, nsp10-U4, nsp10-E1, and nsp10-E2 were rescued by 48 h posttransfection and were categorized as the viable mutants. Mutant nsp10-U1 grew with characteristics similar to those of wt-icMHV, with plaque formation and size comparable to those of the wild-type virus. Mutants nsp10-U3 and nsp10-U4 had reduced plaques sizes compared to wt-icMHV. Mutant nsp10-E1 exhibited smaller plaque sizes, with irregular boundaries, whereas viable mutant nsp10-E2 was the most difficult to observe in further analyses due to variably sized plaques with irregular borders and sizes, many of which were much smaller than those of the wild type (ϳ2 mm versus ϳ5 mm) and barely visible to the eye.
Mutants nsp10-U2, nsp10-U5, and nsp10-U6 exhibited a CPE-negative, RNA positive (CPE Ϫ /RNA ϩ ) phenotype characterized by no detectable CPE in the transfection flask by 48 h posttransfection, although all three generated subgenomic mRNAs at a cycle threshold slightly above the lower limit of detection by real-time PCR (data not shown). However, leader-containing transcripts could not be detected after passage of nsp10-U2 and nsp10-U6. Interestingly, by 72 h posttransfection, nsp10-U5 infections showed signs of CPEs. Sequencing of nsp10-U5 from cells harvested at 48 h posttransfection confirmed the correct mutation (G70A), while sequences generated from infections harvested after 72 h demonstrated a wildtype genotype at the mutant locus. This was repeated with the exact results both times, suggesting that nsp10-U5 reverts to the wild type at two nucleotide positions after 48 h of debilitated replication. Mutants nsp10-E4, nsp10-E5, nsp10-E6, nsp10-E7, nsp10-E8, nsp10-U7, nsp10-U8, and nsp10-U9 were nonviable, as multiple attempts failed to recover virus or detect leadercontaining transcripts.
All of the viable mutants nsp10-U1, nsp10-U3, nsp10-U4, nsp10-E1, and nsp10-E2 were plaque purified and sequenced at the nsp10 locus to confirm that the appropriate mutant allele had been incorporated into the molecular clone, and stocks were grown to a high titer for further analyses.
Phenotype analyses. To determine the effects of the nsp10 mutations on viral growth kinetics and global viral RNA synthesis, we compared rescued mutant nsp10 viruses to wt-icMHV via viral growth curves, Northern blot analysis, and quantitative PCR. DBT cells were infected with wild-type or recombinant viruses bearing the viable nsp10 mutations at an MOI of 0.2 PFU/cell for 1 h, and virus growth was assayed over 16 h. All five viable mutants grew to lower titers than did wt-icMHV at all time points up to 16 h p.i. (Fig. 2A) . However, nsp10-U1 growth was roughly equivalent to that of the wild-type virus, while the other four mutants displayed lower titers at 8 h p.i. By 12 and 16 h p.i., mutants nsp10-E1 and nsp10-E2 were debilitated, replicating to titers about 1 log lower than those of the wild type, while mutants nsp10-U3 and nsp10-U4 were characterized as having more extensive blocks in virus replication ( Fig. 2A) . As overall virus growth was reduced for many of the nsp10 mutant viruses, we next evaluated levels of subgenomic viral transcripts using Northern blotting (Fig. 2B ) and subgenomic and genomic RNA levels using real-time PCR (Fig. 3B, C, and D) . By Northern blotting, all mutants showed a reduction in subgenomic mRNA synthesis at 8 h p.i., with nsp10-E1, nsp10-E2, and nsp10-U4 showing more extensive blocks in subgenomic mRNA synthesis. nsp10-E2 showed an inordinate reduction in subgenomic mRNA synthesis compared to all other mutants and wt-icMHV at 8 h p.i. (Fig. 2B) .
To confirm and extend the Northern blot analysis, real-time PCR was used to quantify viral plus-strand transcripts using primers designed to amplify subgenomic RNA from the N gene or genomic RNA from ORF1a. In agreement with the Northern blot data, quantitative PCR analyses demonstrated that all five mutants were reduced in subgenomic mRNA synthesis at 8 h p.i. compared to wt-icMHV, with more extensive blocks occurring in mutants nsp10-E2, which had a ϳ900-fold reduction, and nsp10-U4, with a ϳ60-fold reduction in mRNA synthesis ( Fig. 3B and D) . All other mutants had reductions of less than 10-fold (Fig. 3D) . Analysis of genomic RNA showed the same trend, with reductions in all mutants, while nsp10-E1 showed an approximately 7-fold reduction, nsp10-E2 showed a 900-fold reduction, and nsp10-U4 showed a 17-fold reduction in genomic RNA at 8 h p.i compared to wt-icMHV ( Fig. 3C  and D) . All other mutants were reduced by less than 10-fold (Fig. 3D) .
A comparison of the reductions of subgenomic and genomic RNAs at 8 h p.i. demonstrated that mutants nsp10-E2 and nsp10-U1 had equivalent reductions of both genomic and subgenomic RNAs (Fig. 3D ). nsp10-E2 had reductions of 900-fold in both genomic and subgenomic RNAs, whereas nsp10-U1 had 2-fold reductions of both (Fig. 3D) .
In contrast, nsp10-E1, nsp10-U3, and nsp10-U4 showed differential effects on subgenomic and genomic RNA synthesis (Fig. 3D) . nsp10-E1 showed a larger reduction in subgenomic than genomic RNA synthesis, with a 7-fold reduction versus a 3.5-fold reduction, respectively, although this difference was not statistically significant (P value of 0.11). Furthermore, nsp10-U3 and nsp10-U4 demonstrated greater reductions in genomic RNA than subgenomic mRNAs (Fig. 3D ). In the case of nsp10-U3, genomic RNA was reduced 3.5-fold, while subgenomic mRNA was reduced only 2-fold, and this difference was statistically significant, with a P value of 0.043. nsp10-U4 also showed a greater decrease in genomic RNAs, with a ϳ60-fold reduction, versus subgenomic mRNA synthesis, with a ϳ17-fold reduction (Fig. 3D) . This difference was statistically significant, with a P value of 0.024.
However, by 12 h p.i., only steady-state levels of nsp10-E2 RNA were significantly reduced compared to those of wticMHV. While nsp10-U4 also displayed slightly reduced levels of subgenomic RNA compared to those of wt-icMHV, all other mutants had recovered viral RNA synthesis to wt-icMHV levels. nsp10-E2 maintained a ϳ3-log reduction through both time points.
These results suggest that in general, mutations in nsp10 result in global attenuation of viral RNA synthesis, particularly early in infection. In addition, some mutations demonstrate greater defects in genomic and/or subgenomic mRNA synthe-FIG. 3. Real-time PCR analysis of nsp10 mutants. Three independent cultures of DBT cells were infected for each of the nsp10 mutants or wt-icMHV at an MOI of 1 PFU/cell and harvested at 8 and 12 h p.i. Total RNA was isolated, reverse transcribed using random hexamers, and amplified by real-time PCR using primers specific for genomic or subgenomic cDNAs or the housekeeping gene GAPDH. (A) Total RNA for each sample was normalized to GAPDH levels by diluting samples until cycle threshold values, as determined by real-time PCR, were roughly equivalent, indicating equivalent concentrations of starting template. (B) Subgenomic mRNAs for the N gene of wt-icMHV and the viable mutant panel were compared, and in agreement with the Northern blot analysis, all five viable mutants showed decreases in subgenomic mRNA synthesis at 8 h p.i., with a more substantial block occurring in mutant nsp10-E2. However, by 12 h p.i., only nsp10-E2 and nsp10-U4 showed reductions in subgenomic mRNA synthesis. Black-and-white hatched bars, RNA harvested at 8 h p.i.; black bars, RNA harvested at 12 h p.i. (C) Genomic RNA analysis using primers to detect ORF1 cDNA showed that all five mutants were compromised in generating genomic RNA at 8 h p.i., with mutants nsp10-E1, nsp10-E2, and nsp10-U4 exhibiting more extensive blocks in genomic RNA synthesis. Genomic RNA synthesis returned to wild-type levels by 12 h p.i. in all mutants except nsp10-E2. See above for explanation of hatched and black bars. (D) Reductions of subgenomic and genomic RNAs from three independent infections at the 8-h time point were compared and analyzed by the paired t test to test the null hypothesis that the reduction in subgenomic mRNAs minus the reduction of genomic RNAs was equal to zero. The null hypothesis was not rejected for mutants nsp10-E2 and nsp10-U1, suggesting that these mutants have an equal reduction in subgenomic and genomic RNAs. The null hypothesis was rejected with P values of less than 0.05 for mutants nsp10-U3 and nsp10-U4, suggesting that these mutants are significantly more defective in generating genomic RNAs than subgenomic mRNAs. Mutant nsp10-E1 appears to be more defective in subgenomic mRNA synthesis than in genomic mRNA synthesis, although this difference was not significant (P value of 0.110). Black bars, genomic RNA; white bars, subgenomic mRNA; ‫,ء‬ statistical significance. Error bars represent standard errors with a 95% confidence interval.
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sis, suggesting that nsp10 plays a critical role in viral RNA regulation of subgenomic and genomic transcripts. Replicase protein processing. To assess the impact of nsp10 mutations on polyprotein processing of viral replicase proteins, we performed radiolabeled immunoprecipitations on infected cell lysates to evaluate the processing and expression levels of nsp10. DBT cells were infected with wt-icMHV and the viable nsp10 mutants at an MOI of 2.0 PFU/cell, pretreated with actinomycin D, and switched to Met-Cys-minus medium, and the cultures were labeled with [
35 S]Cys-Met for 4 h between 8 and 9 h p.i. Cell lysates were fractionated into a crude nuclear pellet and cytoplasmic supernatant. Both the cytoplasmic and nuclear fractions were probed with antibodies directed against nsp10 (VU128), separated on SDS-PAGE gels, and analyzed by autoradiography to detect radiolabeled viral proteins. nsp10 was expressed and processed during infection with each viable nsp10 mutant, although some variation in the amounts of nsp10 was noted among the nsp10 mutant panel (Fig. 4A) . For example, mutant nsp10-E2 appeared to express more proteins than all other viruses despite reduced levels of replication and the transcription phenotypes noted above (Fig. 4A) .
Current data suggest that nsp4-10/11 is expressed as a polyprotein-processing precursor of ϳ150 kDa known as p150, which is subsequently processed by 3CLpro via cis or trans cleavage into the individual replicase proteins (41, 47, 54) . The nsp10-E2 mutant contained two novel bands that registered at ϳ30 kDa and ϳ71 kDa, respectively. By size analyses, viral precursor polyproteins containing nsp9-11 (29 kDa) and nsp7-11(71 kDa) would be the only appropriately sized intermediates to be immunoprecipitated with anti-nsp10 antisera. These data suggest that the nsp10-E2 mutation may cause subtle changes in nsp4-10/11 polyprotein processing, allowing the visualization of the polyprotein precursor intermediates from the C-terminal end of pp1a.
In addition to cytoplasmic lysates, crude nuclear pellets were also probed with anti-nsp10 antibody (Fig. 4B) to determine if ancillary processing intermediates were detectable. Bands corresponding to nsp10 as well as putative intermediates nsp10-11 (ϳ17 kDa), nsp9-11 (ϳ29 kDa), nsp8-11 (ϳ51 kDa), nsp7-11 (ϳ61 kDa), and nsp6-11 (ϳ92 kDa) were present in crude nuclear lysates from nsp10-E2 (Fig. 4B) . In addition to altered processing of the polyprotein, alternate subcellular targeting of mutant nsp10 could account for a reduction in RNA synthesis. nsp10 replicase protein subcellular localization. To determine if the alanine-scanning mutations in nsp10 altered its subcellular localization, IFAs were performed. Previous studies demonstrated that wild-type nsp10 colocalizes with N to distinct punctuate foci in perinuclear regions that are thought to be the site of the CoV replication complexes (Fig. 5A) (3) and not with M, which localizes to sites of assembly. We probed mock-infected and infected cells with antisera directed against nsp10 and either M-or N-specific antibodies to determine if the panel of nsp10 mutants was targeted to sites of replication similarly to the wild-type protein. The predominant nsp10 signal was localized in perinuclear regions for each of the mutants (data not shown for all mutants) (Fig. 5B) . The nsp10 signal was also detected to a lesser extent in the nucleus of DBT cells infected with nsp10-E2 (Fig. 5B ) and is consistent with immunoprecipitation data from crude nuclear lysates for nsp10-E2. In all cases, nsp10 mutants appeared to colocalize predominantly to sites of viral replication at 6.5 h p.i. and were not found in sites of particle maturation and assembly.
Mapping the mutations onto the structure. To identify key residues on the structure of nsp10 that might alter its function, the viable, CPE Ϫ /RNA ϩ , and lethal mutants were modeled onto the solved structure of SARS-CoV nsp10. Homology models were generated for wt-icMHV nsp10 and each of the showed that nsp10 is expressed and processed in each mutant; however, mutants nsp10-U3 and nsp10-E1 demonstrate a reduction in processed nsp10. In addition, nsp10-E1 shows a reduction in p150. Additional products that are not present in any other virus immunoprecipitated with nsp10-E2. These bands likely represent processing intermediates. (B) The crude nuclear pellet was also immunoprecipitated with anti-nsp10 antibody, and mutant nsp10-E2 shows the accumulation of several novel products, which correspond in size to additional processing intermediates.
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MHV nsp10 REGULATES VIRAL RNA SYNTHESIS 6363 16 mutants. The backbone of the SARS-CoV nsp10 structure was then compared to the homology model of MHV nsp10 using the MatchMaker tool under the structure comparison section of Chimera (15, 27) , resulting in a calculated root mean square distance of 0.207 Å. Each mutant was then analyzed in two contexts: (i) by studying the wild-type residues on the MHV homology model and (ii) by comparing those residues to changes predicted by the homology model for each mutant. General trends. Joseph et al. solved the SARS nsp10 structure at a resolution of 1.8 Å and reported that it is a singledomain protein comprised of a pair of antiparallel N-terminal helices stacked against an irregular sheet, which contains a coil-rich C terminus, and two ZFs. nsp10 represents a novel fold and is the first structural representative of this family of zinc finger proteins found so far exclusively in CoVs (22, 23) .
Mapping of all of the mutations onto the homology model of wild-type MHV provided strong support for both ZFs being essential for nsp10 function and, therefore, MHV replication. In general, the core structure of nsp10 surrounding the ZFs was resistant to mutagenesis, and all mutations in the region were lethal (Fig. 6 ). This central core, which extends from amino acid 65 through the C-terminal half of nsp10, is also comprised of 27 residues that are identical among all known CoVs and contains both ZFs. Loops that extend away from the central core, for the most part, tolerated mutations resulting in viable phenotypes. The CPE Ϫ /RNA ϩ mutants were all glycineto-alanine replacements that occurred in the outer loops or in H3 (Fig. 6) .
DISCUSSION
Previous studies predicted that nsp10 acts as a cofactor in the MHV replication complex (3, 28, 30, 41, 44, 50) , which led us to hypothesize that mutations in nsp10 could impact several specific areas of viral RNA synthesis including but not limited to (i) positive-strand synthesis, resulting in reductions of both subgenomic and genomic RNAs; (ii) negative-strand synthesis, resulting in reductions of minus-strand templates; and/or (iii) polyprotein processing, resulting in reductions of essential proteins or intermediates processed from the nascent polyprotein that are essential for the formation of the replication complex. To further examine the functional role of nsp10 in MHV RNA transcription/replication, we applied a reverse-genetics approach incorporating alanine-scanning mutations into the nsp10 gene of the molecular clone of MHV based upon two strategies. First, we hypothesized that conserved regions of nsp10 are essential to its function, so we targeted single residues and a disordered region that are strictly conserved in all CoVs ( Fig.  1 and Table 2 ). Second, we hypothesized that charged residues may provide polar targets on the molecule's surface that facilitate binding to other proteins or nucleic acids; thus, pairs and triplets of charged amino acids were targeted. In all cases, the targeted amino acid(s) was changed to alanine, as alanine eliminates the side chain beyond the ␤-carbon but does not alter the main-chain conformation, nor does it impose extreme electrostatic or steric effects (10) . Of the 16 full-length mutant viral cDNAs generated, eight constructs resulted in no detectable virus, three generated CPE Ϫ /RNA ϩ phenotypes that were lost with passage, and five viruses were rescued with viable phenotypes and further characterized in this study. The high number of nonviable constructs supports previous arguments that nsp10 is essential for CoV replication.
RNA synthesis of each viable mutant was evaluated by analyses of growth kinetics over 16 h and detection of subgenomic versus genomic plus-strand RNA quantities at 8 and 12 h p.i. Growth curve analysis demonstrated that all five viable mutants were compromised in RNA synthesis, with all of them showing reduced growth kinetics compared to those of wticMHV (Fig. 2) . This trend was confirmed by both Northern blot and real-time PCR, which demonstrated that all five mutants were reduced in RNA synthesis at 8 h p.i., although steady-state levels of RNA became nearly equivalent by 12 h p.i. in all mutants except nsp10-E2 and nsp10-U4. Interestingly, mutant nsp10-E2 showed the largest reduction, with a nearly 3-log reduction in subgenomic and genomic RNA at both time points, while nsp10-U4 showed a more extensive reduction in subgenomic RNA synthesis at the earlier time point.
MHV-A59 is known to produce ϳ100 subgenomic mRNAs per genomic RNA, and this ratio remains constant throughout the infectious cycle (39) , although the ratio of the different subgenomic mRNAs varies greatly, with mRNA-7 (N gene) being the most abundant. In addition, negative strands comprise approximately 1% of the total RNA at any time (41) . Mutations that equally reduce subgenomic and genomic RNAs but maintain this ratio would likely introduce a defect in global positive-strand RNA synthesis or a defect in negative-strand template synthesis. In our mutant panel, we observed phenotypes that preserved this ratio as well as those that appeared to alter this ratio with specific reductions in genomic and/or subgenomic RNA synthesis.
Comparisons of the reductions of subgenomic and genomic RNAs for each mutant versus wt-icMHV at 8 h p.i. indicated that mutants nsp10-E1, nsp10-U3, and nsp10-U4 demonstrated differential reductions in subgenomic and genomic RNA synthesis, suggesting that the ratio of subgenomic mRNAs per genomic RNA was altered. In contrast, mutants nsp10-E2 and nsp10-U1 had reductions that were equal in both cases (Fig.  3D) , suggesting that RNA synthesis was reduced, but the ratio of subgenomic mRNAs per genomic RNA remained constant at ϳ100 to 1. However, by 12 h p.i., only nsp10-E2 had subgenomic and genomic RNA levels significantly lower than that of wt-icMHV, with nsp10-U4 genomic RNA synthesis recovering to nearly wild-type levels and subgenomic RNA synthesis recovering to less than a 1-log reduction.
Although it appears that ratios of subgenomic versus genomic RNA eventually recover to wild-type levels by 12 h p.i., differential ratios are evident in mutants nsp10-E1, nsp10-U3, and nsp10-U4 at earlier times of infection. It is worth noting that in similar studies with arterivirus protein nsp11, some mutations produced moderate but significant differences between genomic and subgenomic RNA synthesis (36) . This may be occurring at early times of infection in some nsp10 mutants, perhaps due to a defect in negative-strand template synthesis. Alternatively, a mutation that altered the ability of RdRp template switching could reduce subgenomic mRNA quantities and have no affect on genomic minus-or plus-strand synthesis (31, 32) . We note that real-time and Northern blot analyses measure accumulated levels of RNA and do not measure the actual rates of subgenomic and genomic mRNA transcription.
These data show that four of five mutants exhibited delays in global RNA synthesis at 8 h p.i. that were overcome by 12 h p.i., whereas nsp10-E2 maintained global ϳ3-log reductions throughout. There are at least four mechanisms that could account for global reductions of viral RNA synthesis in the nsp10 mutants: (i) a specific defect in negative-strand or global positive-strand synthesis, (ii) a defect in polyprotein processing that impedes the maturation of the replication complex, (iii) a reduction in the molar quantities of processed nsp10 leading to a reduction in the number of functional replication complexes, or (iv) mislocalization of mutated nsp10 proteins to alternative cellular compartments.
Confocal IFA verified that the mislocalization of the mutated forms of nsp10 did not occur, although ancillary staining of nsp10 was detected in the nucleus of cells infected with nsp10-E2 (Fig. 5B) . This observation led us to examine viral processing in both the cytoplasmic and nuclear fractions of infected cells.
Operating under the hypothesis that mutations in nsp10 might impede the processing of pp1a/pp1ab by disrupting essential contact sites required for protein-protein cis interactions or by interfering with the ability of the polyprotein to fold into a correct orientation to facilitate 3CLpro cleavage, immunoprecipitations were performed to detect nsp10 in the cytoplasmic and nuclear fractions of cells infected with each mutant. In the cytoplasmic fraction, mature forms of nsp10 were processed in each case although at various concentrations (Fig.  4A) , whereas in the nuclear fraction, only mutant nsp10-E2 had detectable proteins (Fig. 4B) . Interestingly, nsp10-E2 processed novel proteins of 65 kDa and 29 kDa in the cytoplasmic fraction (Fig. 4A) , while in the nuclear fraction, proteins of 17 kDa, 29 kDa, 51 kDa, and 65 kDa were detected (Fig. 4B) . These novel proteins correlate in mass to putative intermediates nsp7-11 (ϳ65 kDa), nsp8-11 (ϳ51 kDa), nsp9-11 (ϳ29 kDa), and nsp10-11 (ϳ17 kDa) very well.
Although the processing of mature proteins from the nascent polyprotein in MHV-A59 is not completely understood, there is no evidence that these intermediates exist in wild-type or mock infections (Fig. 4A) . We hypothesize that nsp10-E2 impedes viral processing of the p150 intermediate, resulting in novel processing intermediates that are either transient or nonexistent in wild-type MHV. These psuedoproforms probably accumulate in excess in the cell and likely aggregate with the membranes pulled down with the crude nuclear pellet, although proteins that are 50 kDa and smaller are capable of inefficiently traversing the nuclear pore complex in the absence of active transport (2) . Furthermore, the accumulation of aberrant processing intermediates reduces the number of functional replication complexes, resulting in a global (3-log) reduction of genomic and subgenomic RNAs.
Support for this hypothesis was found in studies with yellow Recent structural studies have solved the X-ray crystal structure of SARS-CoV nsp10 and identified a protein with a novel fold containing two ZFs, predicted to be essential to nsp10 function (22, 51) . We used the SARS nsp10 crystal structure to generate homology models of MHV nsp10 and then mapped our mutations onto the predicted structure. Of note, mutations responsible for the phenotype of nsp10-E2 (D47A and H48A) removed two charged residues predicted to extend to the surface of nsp10. Removing these side chains appeared to alter the loop region without ablating the nsp10 structure completely. Interestingly, both nsp10-E2 and the known temperature-sensitive mutant TS-LA6 [nsp10(Q65E)] map to the same region on the structure of nsp10, in the loop region proximal to the first ZF. In the case of nsp10-E2, replacing Asp47 and His48 with alanines directly alters the hydrogen bonds Lys43-His48, Asp47-Ala-49, and Asp47-Cys46, which allow the loop to collapse inward, rearranging the surface. Replacing a glutamine with glutamic acid at position 65, as in TS-LA6, adds a negative charge to the surface of the protein and forces the loop to extend outward, probably due to repulsion between Glu65, Asp66, and Glu60, which are in the same proximity. This allows a new hydrogen bond to form between Glu65 and His48, which likely extend the loop outward. TS-LA6 has been characterized as having a defect in negative-strand synthesis (41), and we are currently investigating whether or not TS-LA6 shows a reduction in processing efficiency similar to nsp10-E2.
nsp10-U4 targeted a proline at position 59, which also maps to the same region as nsp10-E2 and TS-LA6. We hypothesized that changing this amino acid to alanine would provide more helical character to this disordered region that is conserved throughout the Coronavirus genus. The fact that this mutation conferred differential reductions in genomic and subgenomic RNA synthesis at 8 h p.i. suggests that this disordered region is critical for the regulation of viral RNA synthesis, most likely by interacting with another cofactor or viral RNA. In fact, disordered regions have been implicated as being binding interfaces in other studies (37) .
In addition, the mutation to nsp10-U4 might alter the formation of higher-order structures, particularly in conjunction with mutant nsp10-E1. Changing the lysines to alanines in mutant nsp10-E1 (K24A and K25A) removed positive potential from the surface of nsp10, potentially reducing its binding capacity to another cofactor, or viral RNA. In addition, Lys25 has been implicated as being a key aliphatic residue that interacts with Glu60 of a second nsp10 monomer to stabilize the formation of a trimer. Four of these trimers are predicted to interact to form a large dodecamer, which is hypothesized to function as a transcription factor (51) . However, replacing Lys25 with alanine would remove the interacting side chain and would likely ablate this interaction site. Additional residues stabilize this interface, and they include Val21 from one monomer that interacts with Val57 and Thr58 of another (51) . Mutant nsp10-U4 (P59A) would also likely interfere with this interface at the second interaction site because changing the proline to alanine at position 59 would alter the rotameric positions of neighboring residues 57, 58, and 60, all of which have been predicted to be crucial for trimer formation. The fact that both mutants nsp10-E1 and nsp10-U4 are viable suggests that the dodecamer supercomplex may lack biological relevance. In fact, this structure was solved using the nsp10-nsp11 polyprotein, and experiments in our laboratory have demonstrated that cleavage of nsp11 from nsp10 is essential for replication (Deming et al., unpublished) . Although it was shown that nsp11 extends away from the dodecamer (51), it is not known if this supercomplex can form in the absence of nsp11. A second solved structure of nsp10 suggests that nsp10 may form homodimers or homotrimers (22) .
Mapping all 16 of our mutations onto the homology model of MHV nsp10 provided important insights into its structure. First, mutations that resulted in lethal phenotypes occurred within or near the ZFs. ZFs are protein domains in which Zn 2ϩ contributes to structural stability by binding to residues in the structure to stabilize the domain. There are several classes of ZFs, and these are found in a variety of proteins of diverse function, including proteins involved in the replication and repair of nucleic acids, transcription and translation, cellular signaling and metabolism, and cell proliferation and apoptosis. ZFs most frequently function as interaction sites for the binding of other proteins, nucleic acids, or small molecules (for a recent review, see reference 23). The residues that bind zinc in SARS-CoV nsp10 are strictly conserved throughout the Coronavirus genus and include residues Cys74, Cys77, His83, and Cys90, which bind zinc to form ZF-1, and residues Cys117, Cys120, Cys128, and Cys103, which bind zinc to form ZF-2.
The fact the lethal mutations occurred in or near the ZFs indicates that both ZF motifs are critical for infectivity and RNA synthesis in cell culture. Furthermore, in agreement with data reported previously by Joseph et al. and Su et al. (22, 51) , our data suggest that the C-terminal half of nsp10 comprises a central core, which spans amino acids 65 to 130 and provides the structure necessary for the formation of both ZFs (Fig. 6) . Analyses of the homology models suggest that lethal mutations that mapped within the central core altered the local structural landscape, which prevented the ZFs from forming. We observed three such disruptions. The first disruption, replacement of the essential residues involved in Zn 2ϩ binding, as in mutant nsp10-E5 (Q82A and H83A), was lethal. Second, targeting residues that hydrogen bond directly to the four residues that bind Zn 2ϩ in both ZFs appears to disrupt the formation of the domain. Lethal mutant nsp10-E4 mutates an Arg78-Ser79-Arg80 motif near ZF-1 in which both arginine residues hydrogen bond directly to the residues that bind Zn 2ϩ (Arg78-Cys74 and Arg80-Cys77). Third, altering residues proximal to each ZF probably disrupts the structure enough to prevent ZF formation. Lethal mutants nsp10-E6 (K104A and D105A), nsp10-E7 (H113A and D114A), and nsp10-E8 (R123A and D124A) occur near the ZFs and alter hydrogen bonding. These observations suggest that the structure of the central core is essential for the formation of the ZF domains and provide strong evidence that the ZFs are imperative for nsp10 function.
The N-terminal region of nsp10, which contains mostly loops that extend away from the structural core of nsp10, tolerated mutagenesis. All of the viable mutants were well away from the ZFs and targeted residues that were not involved in maintaining the local structure necessary for the folding of these domains. However, in all cases, these viable mutations had an impact on viral RNA synthesis, suggesting that nsp10 is a critical regulator of viral RNA synthesis.
The results presented in this paper suggest that nsp10 plays a critical role in the regulation of viral RNA synthesis as well as a potential secondary role in polyprotein processing ( Fig. 7A  and B) . Future experiments designed to measure full-length and subgenomic-length replicative-form RNAs and quantitation of negative strands for each viable mutant will help elucidate the exact role of nsp10 in MHV positive-and negativestrand RNA synthesis. The role of nsp10 in processing is likely by cis interactions with a binding partner within the precursor polyprotein. A putative binding site between amino acid positions 48 and 65, which includes the conserved disordered region, may facilitate this interaction. Another possibility is that this region of nsp10 maintains the amino acids necessary for the p150 intermediate to adopt the correct fold to allow other cis interactions, which facilitate the autocleavage of the polyprotein by 3CLpro. Pulse-chase experiments have been designed to further examine the fate of the p150 intermediate in nsp10-E2 infection to verify that processing is reduced in that mutant. Additionally, mapping the mutations generating lethal phenotypes onto the structure of nsp10 supports the hypothesis that both ZFs are essential for replication and demonstrates that a conserved central core maintains the functional domain of nsp10. proteins. nsp10 appears to influence processing in mutant nsp10-E2, which shows evidence of processing intermediates not seen in wticMHV. These data suggest that nsp10 likely interacts with another nsp to facilitate cleavage or maintains a structure that allows the polyprotein to fold into the proper orientation for 3CLpro activation. 
